Clinical Trials Logo

Filter by:
NCT ID: NCT02093026 Completed - Clinical trials for Rheumatoid Arthritis

A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)

Start date: August 2002
Phase: Phase 2
Study type: Interventional

This study will assess the long-term safety and efficacy of repeating treatment with MabThera, in combination with methotrexate and steroids, in patients who were previously randomized into studies WA16291 or WA17043. The anticipated time on study treatment is until Mabthera is available on the local market and the target sample size is 100-500 individuals.

NCT ID: NCT02092961 Terminated - Clinical trials for Rheumatoid Arthritis

Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study

OSKIRA 4 SS
Start date: February 2011
Phase: Phase 2
Study type: Interventional

This is a sub-study of the OSKIRA-4 study, (D4300C0004, NCT01264770) to explore alternative and more sensitive modalities for measuring the beneficial effects of syk inhibition with fostamatinib in patients with active RA. This MRI sub-study was reported later than the main study due to recruitment delays at specialist imaging sites and so is registered and presented entirely separately to the main study results. This study will investigate the impact of treatment on joint activity and damage by assessing synovitis, osteitis, bone erosions and joint space narrowing.

NCT ID: NCT02087098 Completed - Clinical trials for Urinary Bladder, Overactive

A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics

VEST
Start date: June 2014
Phase: N/A
Study type: Observational

This is a 12 month non-interventional study with solifenacin succinate, evaluating the effect of solifenacin on quality of life (QoL) of patients previously treated with antimuscarinics (Males and Females with Overactive Bladder (OAB) symptoms withdrawing their treatment with antimuscarinics because of safety and/or efficacy reasons) - measured by Perception of Treatment Satisfaction (TS-VAS) and to evaluate the effect of solifenacin on quality of life measured by Over Active Bladder-q Short Form (OAB-q SF), EuroQol Group scoring system (EQ-5D-5L).

NCT ID: NCT02086929 Completed - Clinical trials for Major Depressive Disorder

Trazodone Once a Day in Major Depression Disorder

Start date: December 2012
Phase: Phase 3
Study type: Interventional

The study objective is to evaluate the efficacy and safety of trazodone OAD vs venlafaxine extended release (venlafaxine XR) after an 8-week treatment period in patients with major depressive disorder.

NCT ID: NCT02079727 Completed - Knee Osteoarthritis Clinical Trials

Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

Start date: June 12, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to confirm the efficacy and safety of 800 mg Chondroitin 4&6 sulfate (Condrosulf) vs placebo once a day for 6 months in the symptomatic treatment of knee osteoarthritis. A third group, Celecoxib 200 mg (Celebrex) once a day, will be used as active comparator.

NCT ID: NCT02077088 Completed - Atopic Dermatitis Clinical Trials

Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants

Start date: June 2009
Phase: N/A
Study type: Interventional

Addition of prebiotic galactooligosaccharides to hypoallergenic starter formula would lead to decreased allergic (atopic) symptoms in nonbreastfed infants with a positive history of allergy in family

NCT ID: NCT02076841 Completed - Multiple Sclerosis Clinical Trials

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen

SFERA
Start date: July 2013
Phase: N/A
Study type: Observational

To evaluate treatment tolerability, adherence and quality of life (QoL) over 1 year in MS (Multiple Sclerosis) participants who have been switched - due to persistent tolerability issues, particularly injection problems - from a subcutaneous injectable disease-modifying treatment (DMT) given several times a week (Rebif, Betaferon or Copaxone) to once weekly Avonex 30 μg given intra-muscularly. Avonex will be applied by the injection device Avonex Pen.

NCT ID: NCT02064725 Active, not recruiting - Clinical trials for Recurrent or Persistent Endometrial Carcinoma

Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA

Start date: September 2014
Phase: Phase 2
Study type: Interventional

This is an open label, multi-center, single arm phase II study. The study will investigate the efficacy of sodium cridanimod in conjunction with progestin therapy in a population of patients with recurrent or persistent PrR-negative endometrial cancer.

NCT ID: NCT02062320 Completed - Clinical trials for The Efficacy of Analgesic Methods After Caesarean Section

Establishment and Evaluation of a Post Caesarean Acute Pain Service (PCAPS)

PCAPS
Start date: October 2009
Phase: N/A
Study type: Observational

The aim of this study is to compare the efficacy of analgesic methods after Caesarean Section before and after Post Caesarean Acute Pain Service establishing.

NCT ID: NCT02060136 Completed - Clinical trials for Lower Urinary Tract Symptoms

Electronic Method for Recording Lower Urinary Tract Symptoms

Start date: June 2013
Phase: N/A
Study type: Observational

Urinary diaries have proven to be beneficial in assessing lower urinary tract symptoms (LUTS), however they have not achieved widespread acceptance. The likely reason is the fact that the pen and paper diaries are labor intensive for both patient (need to carry a pen and paper and record each event) and doctor (need to transfer, summarize and analyze the data). Hypothesis: Electronic voiding diary, would automate the recording and analysis of data, expedite the process, improve its accuracy and cost effectiveness. Electronic recording of lower urinary tract symptoms (SUF) uses wireless phone and web based technologies to record LUTS remotely and store the data on a secure website which can be accessed by the doctor or patient whenever needed. The goal of this study was to compare its validity and reliability to the traditional micturition chart (MC) recording method - the current gold standard where the patient records the time of micturition and degree of urgency using a pen and paper.